AbCellera Biologics, Inc. (ABCL)
3.56
-0.09
(-2.47%)
USD |
NASDAQ |
Dec 05, 16:00
3.59
+0.03
(+0.84%)
After-Hours: 20:00
AbCellera Biologics Research and Development Expense (TTM): 182.81M for Sept. 30, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Achieve Life Sciences, Inc. | 26.42M |
| Oncolytics Biotech, Inc. | 13.59M |
| Aurinia Pharmaceuticals, Inc. | 29.72M |
| Edesa Biotech, Inc. | 2.547M |
| Lexaria Bioscience Corp. | 8.239M |